Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Botanix Pharmaceuticals Limited ( (AU:BOT) ) has provided an announcement.
Botanix Pharmaceuticals has applied for quotation on the ASX of 4.6 million new ordinary fully paid shares, following the issue of these securities on 18 December 2025. The additional quotation expands the company’s listed share capital, potentially enhancing liquidity in its stock and providing greater flexibility for capital management and future corporate activities.
The most recent analyst rating on (AU:BOT) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Botanix Pharmaceuticals Limited stock, see the AU:BOT Stock Forecast page.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited is an Australian-listed biotechnology company operating in the pharmaceutical sector, with its ordinary fully paid shares traded on the ASX under the code BOT.
Average Trading Volume: 6,029,920
Technical Sentiment Signal: Sell
Current Market Cap: A$226.6M
For a thorough assessment of BOT stock, go to TipRanks’ Stock Analysis page.